2017
DOI: 10.1016/j.clnesp.2017.07.023
View full text
|
|
Share

Abstract: Treatment of Crohn's disease (CD) is challenging. The use of enteral nutrition (EN) as primary therapy in adult patients with CD is not yet supported by high quality evidence. The current evidence is inconclusive with regard to what, how, and why specific type of enteral feed does perform better than others. The fat composition of EN has been suggested to be a key factor in controlling the inflammation in CD [1e3]. We initially conducted a systematic review of previous clinical trials to reanalyse the findings…

Expand abstract